Larvol Delta - Avalyn-Announces-First-Patient-Dosed-in-AURA-Phase-2-Clinical-Trial-Evaluating-AP02-Inhaled-Nintedanib-for-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis

nintedanib inhaled (AP02) - Avalyn Pharma

https://www.globenewswire.com/news-release/2026/03/23/3260821/0/en/Avalyn-Announces-First-Patient-Dosed-in-AURA-Phase-2-Clinical-Trial-Evaluating-AP02-Inhaled-Nintedanib-for-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis.html

Mar 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next